BLGO · Biolargo, Inc.
$0.07
0.00 (-4.93%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The foregoing factors raise substantial doubt about our ability to continue as a going concern, unless we are able to increase revenues, generate cash from operations, and/or generate cash from financing activities.”View the 10-Q filed Aug 14, 2026
Market Cap
$22.35M
Shares
328.73M
Volume · Oct 19
129.99K
Avg daily vol (3M)
403.11K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.07
Open$0.07
Day$0.07–0.07
52W close$0.07–0.20
Avg vol 30d420K
Short int20 · 0.0% float · 1.0d
Short vol27%
DataJan 2020–Oct 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$4.08M
Trailing 12 months
Net income (TTM)
−$18.79M
Trailing 12 months
Revenue growth YoY
-55.1%
Year over year
Operating margin
-444.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.80M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+6.4%
Year over year · more shares
Price change (1Y)
-60.3%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−49%
below
Price vs 50-day avg
−26%
below
RSI (14)
31
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−27%
trailing
6-month return
−58%
trailing
YTD return
−63%
this year
Relative strength
−66%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -98.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Squeeze score
9
low risk · 0–100
Fundamentals
Revenue growth
+4251%
Y/Y
Gross margin
28%
contracting
Free cash flow
$-8.3M
Balance sheet
$3.2M
net cash
Quant / Vol
risk profile
Volatility
89%
annualized · 1-yr
Max drawdown
−66%
past year
ATR
10.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−49%
Bearish
Price vs 50-day avg
−26%
Bearish
RSI (14)
31
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -98.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $0
vs 200-day avg -49%
vs 50-day avg -26%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BLGO
this stock
Biolargo, Inc.
|
$22.35M | -62.5% | -56.3% | — | 0.0% |
|
LIN
Linde PLC
|
$232.08B | +17.7% | +3.0% | 32.5 | 1.3% |
|
AIQUF
L Air Liquide SA /Fi
|
$123.29B | +2.9% | — | — | 0.0% |
|
ECL
Ecolab Inc.
|
$80.78B | +9.8% | +2.2% | 38.7 | 1.9% |
|
SHW
Sherwin Williams Co
|
$80.50B | +3.7% | +2.1% | 30.6 | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
1
- % held
- 0.0%
- Net QoQ
- 0 sh
- Top holder
- FIRST AMERICAN TRUST, FSB
Held
Float
Short & Settlement
Financials
Filings
SEC Filings
Latest
DEF 14A
- Filed
- Oct 19, 2026
- This year
- 13
BioLargo's proxy statement seeks stockholder approval at its December 1, 2026 annual meeting to elect seven directors, advisory-approve executive compensation, and ratify Hacker Johnson & Smith PA as independent registered public accounting firm for fiscal year 2026.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BLGO | -15.6% | -26.6% | -57.8% | -15.6% | -62.5% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -14.1% | -25.7% | -65.5% | -16.1% | -74.9% |